{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:47:13Z","timestamp":1793832433224,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T00:00:00Z","timestamp":1557446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["01KG0912"],"award-info":[{"award-number":["01KG0912"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13023-019-1066-9","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T07:03:17Z","timestamp":1557471797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Effect and safety of treatment with ACE-inhibitor Enalapril and \u03b2-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial"],"prefix":"10.1186","volume":"14","author":[{"name":"on behalf of the German Competence Network for Congenital Heart Defects and the Treat-NMD Neuromuscular Network Investigators list of additional local Investigators and co-workers of the German Competence Network for Congenital Heart Defects and the Treat-NMD Neuromuscular Network","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8455-3416","authenticated-orcid":false,"given":"Sven","family":"Dittrich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Graf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Trollmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Neudorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Heilmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"von der Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Stiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janbernd","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert Dalla","family":"Pozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"M\u00fcller-Felber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"von Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinald","family":"Motz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Korenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Wilichowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Pattathu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich","family":"Ebinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Wiechmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,10]]},"reference":[{"key":"1066_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/humu.22758","volume":"36","author":"CL Bladen","year":"2015","unstructured":"Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Barisic N, Brabec P, Lahdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Viswanathan V, Bayat F, Buccella F, Kimura E, Koeks Z, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Zimowski J, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Jeannet PY, Joncourt F, Diaz-Manera J, Gallardo E, Karaduman AA, Topaloglu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Bellgard MI, Kirschner J, Flanigan KM, Straub V, Bushby K, Verschuuren J, Aartsma-Rus A, Beroud C, Lochmuller H. The TREAT-NMD DMD global database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat. 2015;36:395\u2013402.","journal-title":"Hum Mutat"},{"key":"1066_CR2","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, Group DMDCCW. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol. 2010;9:77\u201393.","journal-title":"Lancet Neurol"},{"key":"1066_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.nmd.2013.12.011","volume":"24","author":"CG Bonnemann","year":"2014","unstructured":"Bonnemann CG, Wang CH, Quijano-Roy S, Deconinck N, Bertini E, Ferreiro A, Muntoni F, Sewry C, Beroud C, Mathews KD, Moore SA, Bellini J, Rutkowski A, North KN. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014;24:289\u2013311.","journal-title":"Neuromuscul Disord"},{"key":"1066_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1474-4422(14)70318-7","volume":"14","author":"SV Raman","year":"2015","unstructured":"Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, Tran T, Smart S, McCarthy B, Taylor MD, Jefferies JL, Rafael-Fortney JA, Lowe J, Roble SL, Cripe LH. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2015;14:153\u201361.","journal-title":"Lancet Neurol"},{"key":"1066_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1055\/s-0034-1398689","volume":"227","author":"S Dittrich","year":"2015","unstructured":"Dittrich S, Tuerk M, Haaker G, Greim V, Buchholz A, Burkhardt B, Fujak A, Trollmann R, Schmid A, Schroeder R. Cardiomyopathy in Duchenne muscular dystrophy: current value of clinical, electrophysiological and imaging findings in children and teenagers. Klinische Padiatrie. 2015;227:225\u201331.","journal-title":"Klinische Padiatrie"},{"key":"1066_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10554-010-9781-2","volume":"28","author":"W Mazur","year":"2012","unstructured":"Mazur W, Hor KN, Germann JT, Fleck RJ, Al-Khalidi HR, Wansapura JP, Chung ES, Taylor MD, Jefferies JL, Woodrow Benson D, Gottliebson WM. Patterns of left ventricular remodeling in patients with Duchenne muscular dystrophy: a cardiac MRI study of ventricular geometry, global function, and strain. The international journal of cardiovascular imaging. 2012;28:99\u2013107.","journal-title":"The international journal of cardiovascular imaging"},{"key":"1066_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00246-004-0689-2","volume":"26","author":"C Kirchmann","year":"2005","unstructured":"Kirchmann C, Kececioglu D, Korinthenberg R, Dittrich S. Echocardiographic and electrocardiographic findings of cardiomyopathy in Duchenne and Becker-Kiener muscular dystrophies. Pediatr Cardiol. 2005;26:66\u201372.","journal-title":"Pediatr Cardiol"},{"key":"1066_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.echo.2008.03.001","volume":"21","author":"L Mertens","year":"2008","unstructured":"Mertens L, Ganame J, Claus P, Goemans N, Thijs D, Eyskens B, Van Laere D, Bijnens B, D\u2019Hooge J, Sutherland GR, Buyse G. Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. J Am Soc Echocardiogr. 2008;21:1049\u201354.","journal-title":"J Am Soc Echocardiogr"},{"key":"1066_CR9","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/S0140-6736(17)31611-2","volume":"390","author":"CM McDonald","year":"2017","unstructured":"McDonald CM, Campbell C, Torricelli RE, Finkel RS, Flanigan KM, Goemans N, Heydemann P, Kaminska A, Kirschner J, Muntoni F, Osorio AN, Schara U, Sejersen T, Shieh PB, Sweeney HL, Topaloglu H, Tulinius M, Vilchez JJ, Voit T, Wong B, Elfring G, Kroger H, Luo X, McIntosh J, Ong T, Riebling P, Souza M, Spiegel RJ, Peltz SW, Mercuri E. Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2017;390:1489\u201398.","journal-title":"Lancet"},{"key":"1066_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, Group DMDCCW. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol. 2010;9:177\u201389.","journal-title":"Lancet Neurol"},{"key":"1066_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nmd.2016.11.012","volume":"27","author":"T Saito","year":"2017","unstructured":"Saito T, Kawai M, Kimura E, Ogata K, Takahashi T, Kobayashi M, Takada H, Kuru S, Mikata T, Matsumura T, Yonemoto N, Fujimura H, Sakoda S. Study of Duchenne muscular dystrophy long-term survivors aged 40 years and older living in specialized institutions in Japan. Neuromuscul Disord. 2017;27:107\u201314.","journal-title":"Neuromuscul Disord."},{"key":"1066_CR12","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1161\/STROKEAHA.116.013678","volume":"47","author":"M Winterholler","year":"2016","unstructured":"Winterholler M, Hollander C, Kerling F, Weber I, Dittrich S, Turk M, Schroder R. Stroke in Duchenne muscular dystrophy: a retrospective longitudinal study in 54 patients. Stroke. 2016;47:2123\u20136.","journal-title":"Stroke"},{"key":"1066_CR13","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/jama.298.10.1171","volume":"298","author":"RE Shaddy","year":"2007","unstructured":"Shaddy RE, Boucek MM, Hsu DT, Boucek RJ, Canter CE, Mahony L, Ross RD, Pahl E, Blume ED, Dodd DA, Rosenthal DN, Burr J, LaSalle B, Holubkov R, Lukas MA, Tani LY. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298:1171\u20139.","journal-title":"JAMA"},{"key":"1066_CR14","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2016;37:2129\u2013200.","journal-title":"Eur Heart J"},{"key":"1066_CR15","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/j.jacc.2016.05.011","volume":"68","author":"CW Yancy","year":"2016","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C. 2016 ACC\/AHA\/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF\/AHA guideline for the Management of Heart Failure: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016;68:1476\u201388.","journal-title":"J Am Coll Cardiol"},{"key":"1066_CR16","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/PCC.0000000000000624","volume":"17","author":"JW Rossano","year":"2016","unstructured":"Rossano JW, Cabrera AG, Jefferies JL, Naim MP, Humlicek T. Pediatric cardiac Intensive Care Society 2014 consensus statement: pharmacotherapies in cardiac critical care chronic heart failure. Pediatr Crit Care Med. 2016;17:S20\u201334.","journal-title":"Pediatr Crit Care Med"},{"key":"1066_CR17","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.jacc.2004.09.078","volume":"45","author":"D Duboc","year":"2005","unstructured":"Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Becane HM. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol. 2005;45:855\u20137.","journal-title":"J Am Coll Cardiol"},{"key":"1066_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ahj.2007.05.014","volume":"154","author":"D Duboc","year":"2007","unstructured":"Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Becane HM. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J. 2007;154:596\u2013602.","journal-title":"Am Heart J"},{"key":"1066_CR19","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.nmd.2016.09.019","volume":"27","author":"B El-Aloul","year":"2017","unstructured":"El-Aloul B, Altamirano-Diaz L, Zapata-Aldana E, Rodrigues R, Malvankar-Mehta MS, Nguyen CT, Campbell C. Pharmacological therapy for the prevention and management of cardiomyopathy in Duchenne muscular dystrophy: a systematic review. Neuromuscul Disord. 2017;27:4\u201314.","journal-title":"Neuromuscul Disord."},{"key":"1066_CR20","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.amjcard.2006.04.020","volume":"98","author":"C Ramaciotti","year":"2006","unstructured":"Ramaciotti C, Heistein LC, Coursey M, Lemler MS, Eapen RS, Iannaccone ST, Scott WA. Left ventricular function and response to enalapril in patients with duchenne muscular dystrophy during the second decade of life. Am J Cardiol. 2006;98:825\u20137.","journal-title":"Am J Cardiol"},{"key":"1066_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/jamacardio.2016.4801","volume":"2","author":"MC Silva","year":"2017","unstructured":"Silva MC, Magalhaes TA, Meira ZM, Rassi CH, Andrade AC, Gutierrez PS, Azevedo CF, Gurgel-Giannetti J, Vainzof M, Zatz M, Kalil-Filho R, Rochitte CE. Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial. JAMA Cardiol. 2017;2:190\u20139.","journal-title":"JAMA Cardiol"},{"key":"1066_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13023-017-0590-8","volume":"12","author":"SV Raman","year":"2017","unstructured":"Raman SV, Hor KN, Mazur W, He X, Kissel JT, Smart S, McCarthy B, Roble SL, Cripe LH. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: results of a two-year open-label extension trial. Orphanet journal of rare diseases. 2017;12:39.","journal-title":"Orphanet journal of rare diseases"},{"key":"1066_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1023\/A:1008853819715","volume":"7","author":"U Ravens-Sieberer","year":"1998","unstructured":"Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res. 1998;7:399\u2013407.","journal-title":"Qual Life Res"},{"key":"1066_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.nmd.2016.07.010","volume":"26","author":"CR Villa","year":"2016","unstructured":"Villa CR, Kaddourah A, Mathew J, Ryan TD, Wong BL, Goldstein SL, Jefferies JL. Identifying evidence of cardio-renal syndrome in patients with Duchenne muscular dystrophy using cystatin C. Neuromuscul Disord. 2016;26:637\u201342.","journal-title":"Neuromuscul Disord"},{"key":"1066_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000336810","volume":"121","author":"SW Kwon","year":"2012","unstructured":"Kwon SW, Kang SW, Kim JY, Choi EY, Yoon YW, Park YM, Ma DW, Chung H, Kwon HM, Rim SJ. Outcomes of cardiac involvement in patients with late-stage Duchenne muscular dystrophy under management in the pulmonary rehabilitation center of a tertiary referral hospital. Cardiology. 2012;121:186\u201393.","journal-title":"Cardiology."},{"key":"1066_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/1532-429X-15-107","volume":"15","author":"KN Hor","year":"2013","unstructured":"Hor KN, Taylor MD, Al-Khalidi HR, Cripe LH, Raman SV, Jefferies JL, O'Donnell R, Benson DW, Mazur W. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function. J Cardiovasc Magn Reson. 2013;15:107.","journal-title":"J Cardiovasc Magn Reson"},{"key":"1066_CR27","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jjcc.2008.08.013","volume":"53","author":"H Ogata","year":"2009","unstructured":"Ogata H, Ishikawa Y, Ishikawa Y, Minami R. Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol. 2009;53:72\u20138.","journal-title":"J Cardiol"},{"key":"1066_CR28","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2169\/internalmedicine.49.3259","volume":"49","author":"T Matsumura","year":"2010","unstructured":"Matsumura T, Tamura T, Kuru S, Kikuchi Y, Kawai M. Carvedilol can prevent cardiac events in Duchenne muscular dystrophy. Intern Med. 2010;49:1357\u201363.","journal-title":"Intern Med"},{"key":"1066_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.003230","volume":"5","author":"SL Roche","year":"2016","unstructured":"Roche SL, Timberlake K, Manlhiot C, Balasingam M, Wilson J, George K, McCrindle BW, Kantor PF. Angiotensin-converting enzyme inhibitor initiation and dose uptitration in children with cardiovascular disease: a retrospective review of standard clinical practice and a prospective randomized clinical trial. J Am Heart Assoc. 2016;5:e003230. \n                    https:\/\/doi.org\/10.1161\/JAHA.116.003230\n                    \n                  .","journal-title":"J Am Heart Assoc."},{"key":"1066_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.pediatrneurol.2008.08.006","volume":"39","author":"Y Takami","year":"2008","unstructured":"Takami Y, Takeshima Y, Awano H, Okizuka Y, Yagi M, Matsuo M. High incidence of electrocardiogram abnormalities in young patients with duchenne muscular dystrophy. Pediatr Neurol. 2008;39:399\u2013403.","journal-title":"Pediatr Neurol"},{"key":"1066_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00246-014-1050-z","volume":"36","author":"JL Jefferies","year":"2015","unstructured":"Thomas TO, Jefferies JL, Lorts A, Anderson JB, Gao Z, Benson DW, Hor KN, Cripe LH, Urbina EM. Autonomic dysfunction: a driving force for myocardial fibrosis in young Duchenne muscular dystrophy patients? Pediatr Cardiol. 2015;36:561\u20138.","journal-title":"Pediatr Cardiol"},{"key":"1066_CR32","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00246-018-1881-0","volume":"39","author":"TD da Silva","year":"2018","unstructured":"da Silva TD, Massetti T, Crocetta TB, de Mello Monteiro CB, Carll A, Vanderlei LCM, Arbaugh C, Oliveira FR, de Abreu LC, Ferreira Filho C, Godleski J, Ferreira C. Heart rate variability and cardiopulmonary dysfunction in patients with Duchenne muscular dystrophy: a systematic review. Pediatr Cardiol. 2018;39:869\u201383.","journal-title":"Pediatr Cardiol."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1066-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-019-1066-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-019-1066-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T19:15:53Z","timestamp":1588965353000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-019-1066-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,10]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1066"],"URL":"https:\/\/doi.org\/10.1186\/s13023-019-1066-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,10]]},"assertion":[{"value":"2 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the ethics-committee of the medical faculty of the Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg (protocol No. 2009\u2013009871-36); informed consent was obtained from all participants and their parents.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"105"}}